BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
6 hedge funds and large institutions have $346K invested in BIMI International Medical Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
4,137% more capital invested
Capital invested by funds: $8.17K → $346K (+$338K)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$452K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$46.6K |
| 3 |
JP Morgan Chase
New York
|
+$11.7K |
| 4 |
N
Natixis
Paris,
France
|
+$7.69K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$658 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3.48K |
BIMI Hedge Fund Activity: Q3 2023 in Review
6 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q3 2023, worth a combined $346K — up 4,137% from $8.17K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BIMI positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $452K. The largest seller was UBS Group, exiting entirely with an estimated $3.48K sold.
- 6 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q3 2023, up from 5 in Q2 2023.
- Funds reported $346K of BIMI International Medical Inc. Common Stock stock for Q3 2023, up 4,137% quarter-over-quarter.
- 2 funds opened new BIMI International Medical Inc. Common Stock positions in Q3 2023 and 1 closed out, a net change of +1 holder.
- The largest BIMI International Medical Inc. Common Stock buyer in Q3 2023 was Hudson Bay Capital Management, an estimated $452K added.
- The largest BIMI International Medical Inc. Common Stock seller in Q3 2023 was UBS Group, an estimated $3.48K sold.
Based on aggregated 13F filings for Q3 2023.